MedTrace Logo

Use of Hypoallergenic (H.A.) Cereals in Children With Diagnosed Allergy to Wheat

NCT01332084 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2012-06-22

No results posted yet for this study

Summary

The investigators plan to launch a Specific Oral Tolerance Induction (SOTI) pilot study in order to assess the efficacy and the safety of hypoallergenic (H.A.) wheat cereals, for children with allergy to wheat. The study has the potential to offer a desensitization treatment option for children allergic to wheat.

The investigators hypothesize that H.A. wheat cereals have similar efficacy with less side effects than native wheat cereals.

Conditions

Interventions

OTHER

HA wheat cereals

HA wheat cereals used in SOTI test and as part of desensitization plan

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Roger Lauener, Prof MD · Universitäts-Kinderklinik Zürich

  • Jacqueline Wassenberg, MD · Département médico-chirurgical de pédiatrie, CHUV, Lausanne

  • Philippe Eigenmann, MD · Adult&Child Allergy Unit, Geneva

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01332084 on ClinicalTrials.gov